New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 13, 2012
16:25 EDTAZN, ZAGG, CLWR, RIGL, BBY, SAM, SOn The Fly: Closing Wrap
Stocks on Wall Street finished lower but off their worst levels amid more political gamesmanship over the fiscal cliff. Both House Speaker John Boehner and Senate Majority Leader Harry Reid made comments regarding the increasing gridlock in negotiations, sending the averages lower just before midday. The averages touched their lows around 2:00 pm, but rallied in the last half hour of trading after reports that the President would meet with Speaker Boehner this evening for further cliff talks... ECONOMIC EVENTS: In the U.S., weekly jobless claims fell 29,000 to 343,000, versus expectations for a drop to 369,000. Producer prices in the month of November fell 0.8%, versus an expected decline of 0.5%. "Core" prices, excluding food and energy, rose 0.1%, which matched expectations. Retail sales rose 0.3% in November, which missed expectations for an increase of 0.5%. In Europe, the region's finance ministers approved the release of more financial aid to Greece and came to terms on a foundation for ECB oversight of a true banking union... COMPANY NEWS: Shares of Clearwire (CLWR) rose 41c, or 14.91%, to $3.16 after Sprint (S) disclosed an offer to buy the remaining stake in the company it does not already own for $2.90 per share. Clearwire said that its talks with Sprint are ongoing. Meanwhile, Sprint shares slipped fractionally, down 2c, or 0.35%, to $5.64... MAJOR MOVERS: Among the notable gainers was Best Buy (BBY), up $1.94, or 15.93%, to $14.12 after the Star Tribune said the company's founder Richard Schulz will soon make an offer for the company. Also higher were ZAGG (ZAGG), up 73c, or 10.27%, to $7.84 after the company announced a $10M share repurchase program, and Boston Beer (SAM), up $17.71, or 15.50%, to $131.94 after raising its FY12 EPS guidance. Among the noteworthy losers was Rigel Pharmaceuticals (RIGL), which fell $2.94, or 34.88%, to $5.49 after an RA drug it is developing in partnership with AstraZeneca (AZN) failed to meet one of its endpoints in a trial. Shares of AstraZeneca also traded down $1.44, or 2.94%, to $47.46... INDICES: The Dow was down 74.73, or 0.56%, to 13,170.72; the Nasdaq was down 21.65, or 0.72%, to 2,992.16; and the S&P 500 was 9.03, or 0.63%, to 1,419.45.
News For CLWR;S;BBY;ZAGG;SAM;RIGL;AZN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 >>
August 26, 2015
10:00 EDTBBYOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:33 EDTSActive equity options trading on open
Subscribe for More Information
06:35 EDTBBYBest Buy upgraded to Strong Buy from Market Perform at Raymond James
Raymond James upgraded Best Buy to Strong Buy from Market Perform and established a $40 price target. The firm said Best Buy's company specific improvements are beginning to offset industry challenges, creating an opportunity to deliver FY16 upside. Raymond James said Best Buy's revenue outlook is beginning to improve and inventory product is starting to recover, which will result in improved earnings.
05:56 EDTBBYStocks with implied volatility below IV index mean; BBY TEVA
Subscribe for More Information
August 25, 2015
16:43 EDTBBYOn The Fly: Top stock stories for Tuesday
Subscribe for More Information
12:20 EDTBBYOn The Fly: Top stock stories at midday
Subscribe for More Information
09:13 EDTBBYOn The Fly: Pre-market Movers
Subscribe for More Information
08:51 EDTBBYBest Buy says 'substantial' amount of leases expiring this year
Best Buy CFO Sharon McCollam said, there are no stores that have negative cash flow but there may be additional store closures.
08:43 EDTBBYBest Buy to sell Apple Care in stores this quarter
Subscribe for More Information
07:08 EDTBBYBest Buy sees Q3 flat to low-single digit domestic revenue growth
Subscribe for More Information
07:06 EDTBBYBest Buy reports Q2 domestic SSS ex-items up 2.7%
Subscribe for More Information
07:02 EDTBBYBest Buy sees no material changes in consumer spending in Q3
Sharon McCollam, Best Buy EVP, CAO and CFO, commented, "It is difficult to know, though, if the recent volatility in the financial markets will affect overall consumer spending. To date, however, we have not seen a measurable impact versus our original expectations. As such, our outlook assumes there will be no material changes in consumer spending in the third quarter. With that said, our year-over-year non-GAAP outlook for Q3 FY16 is as follows. In the Domestic business we are expecting (1) flat to low-single digit revenue growth; and (2) an approximately flat operating income rate change driven by a higher gross profit rate offset by increased SG&A due to inflation and growth-related investments. In the International business, due to the ongoing impacts of the Canadian brand consolidation and foreign currency, we are expecting (1) an International revenue decline of approximately 30% and (2) an International non-GAAP operating income rate in the range of negative 2.5% to negative 3.5%."
07:01 EDTBBYBest Buy reports Q2 adjusted continuing ops EPS 49c, consensus 34c
Reports Q2 revenue $8.53B, consensus $8.29B.
06:06 EDTSStocks with implied volatility below IV index mean; S GOOG
Stocks with implied volatility below IV index mean; Sprint (S) 77, Google (GOOG) 41 according to iVolatility.
August 24, 2015
15:09 EDTBBYNotable companies reporting before tomorrow's open
Notable companies reporting before tomorrow's open, with earnings consensus, include Best Buy (BBY), consensus 34c... Toll Brothers (TOL), consensus 49c... Valspar (VAL), consensus $1.26... DSW (DSW), consensus 42c... Children's Place (PLCE), consensus (33c).
12:29 EDTBBYBest Buy technical comments ahead of results
The shares have been trading in a bearish price channel since a peak of price in March of this year. If the news continues to be bearish, the current trend will likely continue. Next support below the current price of $30.53 is at the $29.50 area, the low of the current price channel. If the news is a sharp negative surprise, next supports will be at $28.11, $27.17, and $26.60. If the news is a bullish surprise, the top of the price channel at $32.78 would be the first important upside objective. It would take a breakout above the channel top to turn the trend back toward bullish. Next resistance above the channel would be at $33.75.
11:31 EDTBBYBest Buy volatility increases into Q2 and outlook
Subscribe for More Information
05:13 EDTAZNAstraZeneca to collaborate with Peregrine on cancer immunotherapy clinical trial
Subscribe for More Information
August 23, 2015
12:35 EDTAZNBiotech firms could see 'billions' in sales from new cancer drugs, Barron's says
Subscribe for More Information
August 21, 2015
06:31 EDTBBYBest Buy volatility into Q2 and outlook
Subscribe for More Information
1 | 2 | 3 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use